can i take aspirin with tirzepatide and Tirzepatide: Drug Interaction Safety Taking Naproxen With Tirzepatide: Safety

How do you test if a peptide is real

Clinical trial data from the SURMOUNT-1 study showed that participants on 5mg weekly lost an average of 15% of their body weight over 72 weeks

Contributing to the occlusion of sick arteries can worsen the condition, potentially leading to thrombosis (170)

Together, this evidence suggests that GIP may drive WL directly, inhibiting caloric intake, indirectly exploiting the anorectic action of GLP-1, or by reducing GLP-1RA adverse effects (59, 60, 63)

The risk in humans isn't fully established, but it's important to keep in mind

In each case, inform patients to resume their regular once weekly dosing schedule [see Dosage and Administration (2.3)]